Digital Ads And Floridians Call On Senator Scott To Pass Bipartisan Legislation To Curb Big Pharma Abusive Monopolies And Boost Lower Cost Generic Competition
FLORIDA — Patients For Affordable Drugs Now (P4ADNow) launched new ads in Florida today as part of its “Push For Competition To Lower Drug Prices.” The campaign includes digital ads and grassroots advocacy, through which Floridians thank Senator Rick Scott for fighting to lower drug prices by ensuring the passage of a package of bipartisan bills that crack down on the drug industry’s anti-competitive practices and promote generic and biosimilar competition.
“Now that the Senate is back from recess, Senator Scott has a real opportunity to advance common sense solutions that will deliver relief to Floridian patients through lower drug prices,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It’s time to curb drug companies’ abuse – through anti-competitive practices that extend monopolies beyond the time intended under law – and allow our system to work, with timely generic and biosimilar competition in the marketplace to lower prices. We urge Senator Scott to act now.”
Below is an example of a digital ad running in Florida:
The campaign also includes TV video ads running in Washington, D.C. that feature two patients who are forced to struggle with the high prices of their prescription drugs and urgently call on the Senate to pass the bipartisan competition bill package.
In addition to Florida, P4ADNow’s campaign includes digital ads and grassroots advocacy in nine additional states, thanking the following senators for fighting to lower drug prices by ensuring competition: Lisa Murkowski (AK), Chuck Grassley (IA), Joni Ernst (IA), Mike Braun (IN), Bill Cassidy (LA), Susan Collins (ME), Josh Hawley (MO), Kevin Cramer (ND), John Cornyn (TX), Ted Cruz (TX), and Mike Lee (UT).
Over the summer, 35 organizations representing patients, consumers, seniors, churches, students, unions and disease advocacy groups sent a letter to the Senate to pass bipartisan patent and regulatory reforms that curb abuses and allow greater competition to lower drug prices. This campaign builds on this momentum by urging Senator Scott to pass legislation to lower drug prices for patients.
###
Patients For Affordable Drugs Now is the only national patient advocacy organization that focuses exclusively on system-changing policies to lower drug prices. P4ADNow is independent, bipartisan and does not accept funding from any organizations that profit from the development or distribution of prescription drugs.
Digital Ads And Texans Call On Senators Cornyn And Cruz To Pass Bipartisan Legislation To Curb Big Pharma Abusive Monopolies And Boost Lower Cost Generic Competition
TEXAS — Patients For Affordable Drugs Now (P4ADNow) launched new ads in Texas today as part of its “Push For Competition To Lower Drug Prices.” The campaign includes digital ads and grassroots advocacy, through which Texans thank Senators John Cornyn and Ted Cruz for fighting to lower drug prices by ensuring the passage of a package of bipartisan bills that crack down on the drug industry’s anti-competitive practices and promote generic and biosimilar competition.
“Now that the Senate is back from recess, Senators Cornyn and Cruz have a real opportunity to advance common sense solutions that will deliver relief to Texan patients through lower drug prices,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It’s time to curb drug companies’ abuse – through anti-competitive practices that extend monopolies beyond the time intended under law – and allow our system to work, with timely generic and biosimilar competition in the marketplace to lower prices. We urge Senators Cornyn and Cruz to act now.”
Below are examples of digital ads running in Texas:
The campaign also includes TV video ads running in Washington, D.C. that feature two Texas patients who are forced to struggle with the high prices of their prescription drugs and urgently call on the Senate to pass the bipartisan competition bill package. The first ad features Jacqueline Garibay, a college student and patient advocate who lives with ankylosing spondylitis, an autoimmune disorder that affects most of her major joints. The second adfeatures Lisa McRipley, a Richmond, Texas patient who lives with multiple sclerosis.
In addition to Texas, P4ADNow’s campaign includes digital ads and grassroots advocacy in nine additional states, thanking the following senators for fighting to lower drug prices by ensuring competition: Lisa Murkowski (AK), Rick Scott (FL), Chuck Grassley (IA), Joni Ernst (IA), Mike Braun (IN), Bill Cassidy (LA), Susan Collins (ME), Josh Hawley (MO), Kevin Cramer (ND), and Mike Lee (UT).
Over the summer, 35 organizations representing patients, consumers, seniors, churches, students, unions and disease advocacy groups sent a letter to the Senate to pass bipartisan patent and regulatory reforms that curb abuses and allow greater competition to lower drug prices. This campaign builds on this momentum by urging Senators Cornyn and Cruz to pass legislation to lower drug prices for patients.
###
Patients For Affordable Drugs Now is the only national patient advocacy organization that focuses exclusively on system-changing policies to lower drug prices. P4ADNow is independent, bipartisan and does not accept funding from any organizations that profit from the development or distribution of prescription drugs.
Digital Ads And Hoosiers Call On Senator Braun To Pass Bipartisan Legislation To Curb Big Pharma Abusive Monopolies And Boost Lower Cost Generic Competition
WASHINGTON, D.C — Patients For Affordable Drugs Now (P4ADNow) launched a six-figure ad campaign today as part of its “Push For Competition To Lower Drug Prices.” The campaign includes two video ads featuring patients who are forced to struggle with the high prices of their prescription drugs and urgently call on the Senate to pass a package of bipartisan bills that crack down on the drug industry’s anti-competitive practices and close regulatory loopholes to promote generic and biosimilar competition to lower drug prices for patients. Jacqueline Garibay is a college student who lives with ankylosing spondylitis, and Lisa McRipley lives with multiple sclerosis. The 30-second videos are running on digital and TV platforms in Washington, D.C. The campaign also includes digital static ads as well as grassroots advocacy across ten states, through which people will call and write their senators to demand the timely passage of the competition bill package.
“Now that the Senate is back from recess, there is a real opportunity to advance common sense solutions supported by both Republicans and Democrats in the Senate that will deliver relief to patients through lower drug prices,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It’s time to curb drug companies’ abuse – through anti-competitive practices that extend monopolies beyond the time intended under law – and allow our system to work, with timely generic and biosimilar competition in the marketplace to lower prices. We urge the Senate to act now.”
The first ad features Jacqueline Garibay, a college student and patient advocate who lives with ankylosing spondylitis, an autoimmune disorder that affects most of her major joints. “The last time we had to buy my medication, I decided to forgo it. We just couldn’t afford $6,000 a month,” Jacqueline of Austin, Texas, says in the ad. “While my classmates are thinking about their careers, their weddings, all I can think about is how I’m going to afford my medication.”
Watch Jacqueline’s ad here.
The second ad features Lisa McRipley, a Richmond, Texas patient who lives with multiple sclerosis. “The medication to treat my MS is nearly $7,500 a month. But without it, my disease will progress irreversibly – I could lose my independence solely because of outrageous drug prices,” Lisa, a medicare beneficiary, says in the ad. “Congress can fix this. We can’t afford to wait.”
Watch Lisa’s ad here.
P4ADNow’s campaign includes digital ads as well as grassroots advocacy in ten states, thanking the following senators for fighting to lower drug prices by ensuring competition: Lisa Murkowski (AK), Rick Scott (FL), Chuck Grassley (IA), Joni Ernst (IA), Mike Braun (IN), Bill Cassidy (LA), Susan Collins (ME), Josh Hawley (MO), Kevin Cramer (ND), John Cornyn (TX), Ted Cruz (TX), and Mike Lee (UT).
See example ads here:
Over the summer, 35 organizations representing patients, consumers, seniors, churches, students, unions and disease advocacy groups sent a letter to the Senate to pass bipartisan patent and regulatory reforms that curb abuses and allow greater competition to lower drug prices. This campaign builds on this momentum.
###
Patients For Affordable Drugs Now is the only national patient advocacy organization that focuses exclusively on system-changing policies to lower drug prices. P4ADNow is independent, bipartisan and does not accept funding from any organizations that profit from the development or distribution of prescription drugs.
TV, Digital Ads, And Patient Lobbyists Call On Senators To Pass Bipartisan Legislation To Curb Big Pharma Abusive Monopolies And Boost Lower Cost Generic Competition
WASHINGTON, D.C — Patients For Affordable Drugs Now (P4ADNow) launched a six-figure ad campaign today as part of its “Push For Competition To Lower Drug Prices.” The campaign includes two video ads featuring patients who are forced to struggle with the high prices of their prescription drugs and urgently call on the Senate to pass a package of bipartisan bills that crack down on the drug industry’s anti-competitive practices and close regulatory loopholes to promote generic and biosimilar competition to lower drug prices for patients. Jacqueline Garibay is a college student who lives with ankylosing spondylitis, and Lisa McRipley lives with multiple sclerosis. The 30-second videos are running on digital and TV platforms in Washington, D.C. The campaign also includes digital static ads as well as grassroots advocacy across ten states, through which people will call and write their senators to demand the timely passage of the competition bill package.
“Now that the Senate is back from recess, there is a real opportunity to advance common sense solutions supported by both Republicans and Democrats in the Senate that will deliver relief to patients through lower drug prices,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It’s time to curb drug companies’ abuse – through anti-competitive practices that extend monopolies beyond the time intended under law – and allow our system to work, with timely generic and biosimilar competition in the marketplace to lower prices. We urge the Senate to act now.”
The first ad features Jacqueline Garibay, a college student and patient advocate who lives with ankylosing spondylitis, an autoimmune disorder that affects most of her major joints. “The last time we had to buy my medication, I decided to forgo it. We just couldn’t afford $6,000 a month,” Jacqueline of Austin, Texas, says in the ad. “While my classmates are thinking about their careers, their weddings, all I can think about is how I’m going to afford my medication.”
Watch Jacqueline’s ad here.
The second ad features Lisa McRipley, a Richmond, Texas patient who lives with multiple sclerosis. “The medication to treat my MS is nearly $7,500 a month. But without it, my disease will progress irreversibly – I could lose my independence solely because of outrageous drug prices,” Lisa, a medicare beneficiary, says in the ad. “Congress can fix this. We can’t afford to wait.”
Watch Lisa’s ad here.
P4ADNow’s campaign includes digital ads as well as grassroots advocacy in ten states, thanking the following senators for fighting to lower drug prices by ensuring competition: Lisa Murkowski (AK), Rick Scott (FL), Chuck Grassley (IA), Joni Ernst (IA), Mike Braun (IN), Bill Cassidy (LA), Susan Collins (ME), Josh Hawley (MO), Kevin Cramer (ND), John Cornyn (TX), Ted Cruz (TX), and Mike Lee (UT).
See example ads here:
Over the summer, 35 organizations representing patients, consumers, seniors, churches, students, unions and disease advocacy groups sent a letter to the Senate to pass bipartisan patent and regulatory reforms that curb abuses and allow greater competition to lower drug prices. This campaign builds on this momentum.
###
Patients For Affordable Drugs Now is the only national patient advocacy organization that focuses exclusively on system-changing policies to lower drug prices. P4ADNow is independent, bipartisan and does not accept funding from any organizations that profit from the development or distribution of prescription drugs.
Welcome to the Week in Review.
1. 🎉First 10 Drugs Eligible For Negotiation Announced 🎉
2. Patient Advocate Steven Hadfield Introduces The President 🇺🇸
3. Future Reforms To Address Patent Abuse And PBMs
Have a great weekend!
“I’m so grateful to President Biden for passing the Inflation Reduction Act. It’s already made a huge difference in my life.”
WASHINGTON, D.C. — Patient advocate Steven Hadfield from North Carolina, who is on Medicare and lives with a rare blood cancer and type 2 diabetes, introduced and thanked President Biden for passing the Inflation Reduction Act and shared his story about the high prices of his own prescription drugs earlier this week. Today, the White House released a video that highlights Steven and President Biden’s conversation just ahead of the president’s Tuesday speech where he celebrated the announcement of the first 10 eligible drugs for which Medicare will negotiate lower prices.
“I have been a hard worker all my life. And I’ve always had to work multiple jobs simultaneously so I can afford my medications…But I’m afraid that if I retire, I won’t be able to afford what I need to survive,” Steven shared ahead of introducing the president. “Thanks to President Biden, that’s changing. He’s finally ending Big Pharma’s one-sided pricing power, and giving seniors like me a break.”
Steven takes numerous medications to keep him alive. One drug, Brukinsa, which treats his rare blood cancer, comes with a price tag of almost $16,000 a month. Thankfully, his diabetes medication is already significantly lowered from the Inflation Reduction Act. Steven used to pay up to $400 per month for his Lantus insulin, but thanks to the copay cap for Medicare beneficiaries in the new law, Steven now receives it for $35 a month. And another one of Steven’s diabetes drugs, Januvia, which carries a monthly list price of $547, was one of the first 10 drugs announced as eligible for negotiation.
Watch Steven’s remarks introducing the president here.
Watch the White House video featuring Steven on Facebook, Twitter, and Instagram.
###
Patients On Listed Drugs React With Joy To Lower Prices On The Horizon; Long Awaited Relief
WASHINGTON, D.C. — The following statement was issued by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now, in response to the Centers for Medicare and Medicaid Services (CMS) announcement of the first ten drugs for which Medicare will negotiate lower prices as part of the Inflation Reduction Act:
“This is a momentous day for patients across the country. Finally beginning to undo the nearly 20-year ban on Medicare using its purchasing power to get lower prices, Medicare will now negotiate for a better deal for these ten high-cost drugs. The list includes essential life-saving medications – cancer treatments, blood thinners, autoimmune disease treatments, diabetes drugs – that people in this country have been paying unjustified amounts for decades, while drug companies have used Medicare as a piggy bank raising prices to hit profit targets and trigger executive bonuses.
“I am one of millions of people in this country who take Eliquis (apixaban), a blood thinner that has a list price of almost $7,000 in the U.S. because its maker, Bristol-Myers Squibb, has blocked competition. In Canada, where there is a generic, the price is less than $1,700. With negotiations, millions of patients will finally get a more affordable price for drugs like Eliquis.
“We look forward to continuing to work with CMS and the Department of Health and Human Services (HHS) to ensure the law is implemented despite opposition from Big Pharma, and that patients finally begin to get a better deal for these ten high-priced medications and another 50 by 2029. We’ve been waiting far too long for this relief. This is just the beginning and we will continue pushing on all fronts to lower drug prices for everyone.”
The following statements are from patients around the country who are on some of the ten drugs on the list to be negotiated first for lower prices:
The prices of the following ten drugs will be the first to be negotiated by Medicare:
###
Dear Big Pharma, your top 10 most expensive drugs “Used To Be” some of the world’s most unaffordable, but with Medicare negotiation, we won’t have to pay your unjustified prices for a “Single [Drug] Soon.” “Yours Truly,” patients.
Welcome to the Week in Review.
1. Pushing Back On Negotiation Lawsuits
2. The Widely-Supported Inflation Reduction Act
3. Big Pharma Greed & Influence
Have a great weekend!
